SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.278
AS - Asia 8.102
EU - Europa 4.598
SA - Sud America 1.409
AF - Africa 118
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 34.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.005
SG - Singapore 3.260
CN - Cina 2.309
BR - Brasile 1.197
UA - Ucraina 1.024
HK - Hong Kong 884
DE - Germania 787
IT - Italia 659
TR - Turchia 626
GB - Regno Unito 545
VN - Vietnam 506
PL - Polonia 405
FI - Finlandia 277
SE - Svezia 272
RU - Federazione Russa 258
MX - Messico 141
ID - Indonesia 110
IN - India 104
CA - Canada 100
FR - Francia 100
AR - Argentina 91
NL - Olanda 65
BD - Bangladesh 63
ZA - Sudafrica 53
ES - Italia 51
JP - Giappone 42
AT - Austria 40
BE - Belgio 33
EC - Ecuador 33
IQ - Iraq 30
UZ - Uzbekistan 25
IR - Iran 22
CO - Colombia 21
PK - Pakistan 21
KR - Corea 18
LT - Lituania 18
VE - Venezuela 18
MA - Marocco 14
CL - Cile 13
CZ - Repubblica Ceca 11
EG - Egitto 11
PY - Paraguay 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
PE - Perù 9
UY - Uruguay 9
AL - Albania 7
AU - Australia 7
CH - Svizzera 7
HN - Honduras 7
SA - Arabia Saudita 7
ET - Etiopia 6
GR - Grecia 6
KE - Kenya 6
MY - Malesia 6
OM - Oman 6
RO - Romania 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
IE - Irlanda 5
IL - Israele 5
JO - Giordania 5
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
EU - Europa 4
KZ - Kazakistan 4
MD - Moldavia 4
PS - Palestinian Territory 4
SN - Senegal 4
JM - Giamaica 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
LB - Libano 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
SS - ???statistics.table.value.countryCode.SS??? 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
FK - Isole Falkland (Malvinas) 1
GY - Guiana 1
Totale 34.505
Salva come PNG Salva come JPEG
Città #
Fairfield 2.681
Woodbridge 2.480
Singapore 1.874
Ashburn 1.862
Houston 1.576
Jacksonville 1.139
Seattle 1.060
Chandler 993
Ann Arbor 892
Hong Kong 883
Wilmington 879
Cambridge 857
Santa Clara 678
Beijing 668
Izmir 412
Warsaw 395
Nanjing 335
Los Angeles 275
Princeton 251
San Diego 233
Dallas 204
Boardman 194
Ho Chi Minh City 151
Ferrara 150
New York 150
Munich 142
Milan 126
Addison 121
Dong Ket 96
Shanghai 95
Nanchang 94
São Paulo 93
Shenyang 91
Hanoi 88
Mexico City 88
Jakarta 83
Hefei 82
Dearborn 76
Hebei 68
Tianjin 68
Chicago 61
London 61
Mountain View 59
Jinan 57
Bremen 55
Jiaxing 53
Brooklyn 50
The Dalles 45
Changsha 44
Kunming 42
Montreal 42
Turku 42
Falls Church 40
Moscow 40
Redwood City 39
Tokyo 39
San Francisco 38
Denver 37
Atlanta 36
Hangzhou 36
Rio de Janeiro 36
San Mateo 36
Columbus 35
Norwalk 35
Falkenstein 34
Guangzhou 33
Johannesburg 32
Zhengzhou 32
Brussels 31
Buffalo 31
Orem 31
Boston 29
Stockholm 29
Poplar 28
Rome 28
Tappahannock 28
Toronto 28
Orange 27
Manchester 26
Ningbo 26
Nuremberg 26
Belo Horizonte 25
Des Moines 25
Phoenix 25
Chennai 24
Verona 24
Auburn Hills 23
Taizhou 23
Tashkent 23
Washington 22
Brasília 21
Amsterdam 20
Philadelphia 20
Helsinki 18
Porto Alegre 18
Vienna 18
Biên Hòa 17
Mumbai 17
Ankara 16
Curitiba 16
Totale 24.635
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 312
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 263
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 250
Loss of miR-204 expression is a key event in melanoma 247
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 239
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 239
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 235
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 235
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 234
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 222
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 217
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 215
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 215
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 211
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 209
Identification of microRNA activity by Targets' Reverse EXpression. 208
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 207
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 207
MicroRNA e cancro 207
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 205
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 203
A microRNA DNA methylation signature for human cancer metastasis 202
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 197
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 196
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 194
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 194
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 193
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 192
Reprogramming of miRNA networks in cancer and leukemia 191
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 190
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 190
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 189
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 189
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 189
MicroRNA involvement in hepatocellular carcinoma 188
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 186
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 185
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 185
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 183
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 183
A microRNA signature of hypoxia 183
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 183
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 182
MicroRNA expression profiling in human Barrett's carcinogenesis. 182
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 180
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 180
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 175
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 175
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 174
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 174
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 174
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 171
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 170
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 170
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 170
Aberrant FHIT transcripts in Merkel cell carcinoma 167
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 166
Extensive modulation of a set of microRNAs in primary glioblastoma 166
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 165
Espressione dei MicroRNA nei carcinomi mammari 165
Knockout mice reveal a tumor suppressor function for Testin 164
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 164
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 163
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 163
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 163
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 161
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 160
Tumor suppressor functions of ARLTS1 in lung cancers 159
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 159
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 159
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 158
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 158
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 158
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 157
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 157
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 156
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 156
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 155
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 155
MicroRNA genes are frequently located near mouse cancer susceptibility loci 153
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 153
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 153
The role of microRNA genes in papillary thyroid carcinoma 153
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 153
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 152
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization 151
MicroRNA deregulation in human thyroid papillary carcinomas 151
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock 150
Oncogenic role of miR-483-3p at the IGF2/483 locus 149
MicroRNA profiles discriminate among colon cancer metastasis 149
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 148
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 148
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 148
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 148
MicroRNA-133 controls cardiac hypertrophy 147
microRNA involvement in hepatocellular carcinoma 146
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 145
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 144
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 144
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 144
Totale 18.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.325
Totale 159.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.067 0 0 0 0 0 340 155 389 98 406 401 278
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20254.586 144 94 387 137 585 360 160 283 851 471 649 465
2025/20267.441 1.194 650 1.219 1.860 1.889 629 0 0 0 0 0 0
Totale 34.844